title: Reply to the letter to the editor by Edelstein PH.
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan. Electronic address: hiroki-s@ma.catvy.ne.jp.
authors.forename: Hiroki
authors.initials: H
authors.lastname: Suzuki
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Midori
authors.initials: M
authors.lastname: Nishizuka
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Tomoka
authors.initials: T
authors.lastname: Ara
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Mari
authors.initials: M
authors.lastname: Watanabe
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Mami
authors.initials: M
authors.lastname: Morita
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Chisa
authors.initials: C
authors.lastname: Sato
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Fumihiro
authors.initials: F
authors.lastname: Tsuchida
authors.affiliation: Department of Microbiology, Yamagata Prefectural Institute of Public Health, Japan.
authors.forename: Junji
authors.initials: J
authors.lastname: Seto
authors.affiliation: Department of Bacteriology I, National Institute of Infectious Diseases, Japan.
authors.forename: Junko
authors.initials: J
authors.lastname: Amemura-Maekawa
authors.affiliation: Department of Bacteriology I, National Institute of Infectious Diseases, Japan.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Kura
authors.affiliation: Department of Respiratory Medicine, Saiseikai Yamagata Saisei Hospital, Japan.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Takeda
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D016952:Legionella pneumophila / Q000302:isolation & purification*; D007877:Legionnaires' Disease / Q000188:drug therapy*; D008297:Male; D018410:Pneumonia, Bacterial / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents; D015378:Imipenem
keywords: Imipenem/cilastatin; Legionella pneumonia; Urinary antigen-negative patients